Clinically Proven, NHS Trusted, Transforming Pelvic Health

The Evidence-Based Digital Solution Recommended by Healthcare Professionals and Valued by Patients

NHS Partnerships

Working Closely with the NHS

Contracted by the NHS 2025
NHS Innovation Accelerator (NIA)
NHS

Clinical Studies and Research

Clinically proven results

NHS Evaluation Report
Our first NHS pilot, 2020

Clinical Evidence: Outcomes by Symptom

Urinary incontinence

92%

of women said their bladder leaking improved

Pelvic Organ Prolapse

92%

of women said their prolapse symptoms improved

Painful Sex (Dyspareunia)

82%

of women said painful sex improved

Diastasis Recti

93%

of women said their abdominal separation improved

Emotional Wellbeing

90%

of women said they felt better in themselves

Back Pain

90%

of women said their back pain improved

Patient Voice and Health Equity

96%

of women would recommend MUTU

Patient Feedback

Expert Feedback

Endorsed by healthcare professionals

Here are endorsements from MUTU System’s Medical Ambassadors, highlighting the program’s effectiveness and their personal experiences:

Industry Partnerships

MUTU System partnered with TENA, the globally recognised leader in continence management and intimate health care. The collaboration reflected a shared commitment to raising awareness, reducing stigma, and improving support for pelvic health in women, particularly during the postpartum period.

The partnership supported aligned goals in education, advocacy, and access to solutions for women experiencing pelvic floor dysfunction, incontinence or prolapse symptoms. MUTU and TENA worked to bridge the gap between clinical understanding and accessible, evidence-based self-management tools.

Corporate Health Initiatives

MUTU is implemented in employee wellbeing and maternity return-to-work programmes, helping improve retention and satisfaction among new parent employees. Examples include:

Postpartum Plan

Integrated support programme for new parents via employee wellness.

Heka

UK employee wellbeing platform offering MUTU as part of holistic corporate care solutions.

International Partnerships

MUTU System operates international strategic collaborations:

Optum Now / UnitedHealth Group

MUTU has met medical and legal due diligence for inclusion on Optum Now, UHG’s digital health platform. This enables MUTU access through one of the U.S.’s largest employer and healthcare ecosystems, demonstrating compliance with rigorous standards.

Startup Health

MUTU is part of Startup Health’s global innovation portfolio, recognising its impact in women’s health and digital care delivery. This inclusion validates MUTU’s credibility and visibility among global health investors and care leaders.

Compliance, Security, and Industry Recognition

MUTU System has been independently reviewed by ORCHA (the Organisation for the Review of Care and Health Apps), scoring 91% in its Baseline Review (2022).

Why MUTU is Unique

MUTU System is supported not only by clinical trials but also by independent NHS evaluation—such as the 2024 NHS Kent Surrey Sussex Health Innovation Network report—highlighting its significant impact and value as a digital maternal health intervention.

MUTU System stands apart from other postpartum solutions in key areas that matter most to healthcare professionals and decision-makers:

  • Clinical Credibility: Clinically validated through independent NHS trials, including a 2022 study with Norfolk & Norwich University Hospital NHS Trust. This level of medical evidence is rarely seen in consumer-facing postpartum programs.

  • Evidence-Based Results: Quantified symptom improvements across multiple studies and real-world data, including pelvic floor recovery, diastasis recti improvement, reduced pain, and enhanced emotional wellbeing.

  • NHS Partnerships: A unique, proven track record of formal collaboration with the NHS, including a 2025 contract with Kent and Medway NHS and recognition through the NHS Innovation Accelerator.

  • Compliance Standards: UK GDPR compliant, clinical safety assured to DCB0129, and independently reviewed by ORCHA, which scored MUTU System 91% in its Baseline Review (2022).

  • Expert Leadership: MUTU System was founded by Wendy Powell, a recognised leader in women’s health innovation and an NHS Innovation Accelerator Fellow (2021). Wendy is an internationally respected speaker and advocate for pelvic health, with over a decade of work influencing maternity care policy and innovation.

This unique combination of clinical evidence, institutional trust, expert leadership, and user-friendly accessibility positions MUTU as the most credible and impactful solution in the pelvic health care space.

Medical Professionals: Ready to Recommend MUTU?

FAQs for healthcare professionals

You can refer to try MUTU directly via our website. When signing up they will get a free trial before purchase is completed. If you’re looking to procure or commission MUTU for your hospital, clinics or healthcare system, please contact us.

To discuss commissioning or working with us for your NHS Trust, PPHS services, clinic, hospital or region, please contact our NHS Partnerships Lead, Ben Hulme at Hulme Redwood.

To discuss working with us as an Ambassador, please get in touch with Wendy, NIA Fellow and Director at MUTU.

Data sources

These figures come from MUTU’s own customer surveys, completed by women at three, six and twelve weeks. The figures shown are what women reported at twelve weeks. MUTU has also been independently evaluated for the NHS by Unity Insights in 2024, and ran its first NHS pilot at Norfolk and Norwich University Hospitals in 2020.

Unlock 15% off the MUTU System program!

Get ‘Notes from MUTU’ direct to your inbox